| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/27/2004 | US6727243 Solid solution dissolved in a polymer |
| 04/27/2004 | US6726992 Nano-engineered phosphors and related nanotechnology |
| 04/27/2004 | US6726935 Secreted from venom gland of a toad; formulated as ointment, suspension, gel, spray, patch or solution; for preventing premature, noncontrolled ejaculation and/or sexual hypersensitivity |
| 04/27/2004 | US6726934 Micro-particulate and nano-particulate polymeric delivery system |
| 04/27/2004 | US6726933 Rod-shaped mesoporous powder, humectant adsorbing powder, and cosmetic preparation using the same |
| 04/27/2004 | US6726931 Process for preparing oral sustained-release formulation of felodipine |
| 04/27/2004 | US6726930 Sustained release heterodisperse hydrogel systems for insoluble drugs |
| 04/27/2004 | US6726929 Pharmaceutical mixture comprising a profen |
| 04/27/2004 | US6726928 Process for preparing solid dosage forms for unpalatable pharmaceuticals |
| 04/27/2004 | US6726927 Comprises core granulation formed by dry mixing drug or its salt with alkaline substance and pharmaceutical excipients which can be quantitatively filled into an empty hard gelatin capsule; provides gastrointestinal cytoprotective benefit |
| 04/27/2004 | US6726926 Disaccharide protector; frozen; preserved for longer than one year; shows excellent restoration ability in water |
| 04/27/2004 | US6726925 Bi-layer membrane comprising phospholipid and lysolipid; drug delivery, medical diagnosis |
| 04/27/2004 | US6726924 Oral liposomal delivery system |
| 04/27/2004 | US6726923 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix |
| 04/27/2004 | US6726922 Process and composition for temporarily suppressing pain |
| 04/27/2004 | US6726920 Implantable drug delivery patch |
| 04/27/2004 | US6726919 For inducing or maintaining anesthesia or sedation in a patient |
| 04/27/2004 | US6726918 Implanting bioerodible particle comprising steroidal antiinflammatory agent and polymer that delivers dexamethasone to vitreous; ophthalmology; uveitis, vision defects |
| 04/27/2004 | US6726915 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides |
| 04/27/2004 | US6726860 Production scale method of forming microparticles |
| 04/27/2004 | US6726791 Method for producing a layered product |
| 04/27/2004 | US6726678 Implantable reservoir and system for delivery of a therapeutic agent |
| 04/27/2004 | US6726673 Applying androgen transdermal therapeutic system to skin, applying apparatus capable of generating heat in manner that mimics endogenous circadian androgen production, heating system to increase delivery rate, simulating natural pattern |
| 04/27/2004 | US6726650 Automatic liquid injection system and method |
| 04/27/2004 | CA2296244C Adjuvants for use in vaccines |
| 04/27/2004 | CA2290974C Solubilized sertraline compositions |
| 04/27/2004 | CA2271750C Prolonged anesthesia in joints and body spaces |
| 04/27/2004 | CA2123651C Process of sugarless hard coating and products obtained therefrom |
| 04/27/2004 | CA2123650C Process for sugarless coating and products obtained according to the process |
| 04/24/2004 | CA2446094A1 Pharmaceutical dosage form and method of making |
| 04/22/2004 | WO2004033662A2 Optimizing giant unilamellar vesicle (guv) growth in a physiological buffer and artificial cell based biosensor |
| 04/22/2004 | WO2004033620A2 Methods and compositions for therapeutic use of rna interference |
| 04/22/2004 | WO2004033484A2 Use of stable glutamine derivatives to improve drug absorption |
| 04/22/2004 | WO2004033483A2 Liposomal system and method of using same |
| 04/22/2004 | WO2004032980A1 Gamma irradiation of solid nanoparticulate active agents |
| 04/22/2004 | WO2004032972A1 An oral formulation of methylglyoxal and its imino acid conjugates for human use |
| 04/22/2004 | WO2004032970A2 Carriers attached to blood cells |
| 04/22/2004 | WO2004032965A1 Endogenous repair factor production promoters |
| 04/22/2004 | WO2004032963A2 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 04/22/2004 | WO2004032945A1 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations |
| 04/22/2004 | WO2004032944A1 Composition for treating hemorrhoids |
| 04/22/2004 | WO2004032942A1 Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin |
| 04/22/2004 | WO2004032920A1 Stabilized pharmaceutical preparation comprising an amorphous active substance |
| 04/22/2004 | WO2004032910A1 Injectable 2,6-diisopropylphenol-containing anesthetic composition and methods |
| 04/22/2004 | WO2004032909A2 Stabilized pharmaceutical composition containing basic excipients |
| 04/22/2004 | WO2004032907A1 Painlessly removable transdermal medical patch |
| 04/22/2004 | WO2004032906A1 Gastro-retentive levodopa delivery form |
| 04/22/2004 | WO2004032905A1 Gabapentin tablets and methods for their preparation |
| 04/22/2004 | WO2004032904A1 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate |
| 04/22/2004 | WO2004032903A2 Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier |
| 04/22/2004 | WO2004032902A1 Solid particulate antifungal compositions for pharmaceutical use |
| 04/22/2004 | WO2004032901A1 Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof |
| 04/22/2004 | WO2004032900A1 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 04/22/2004 | WO2004032899A1 Antibiotic formulation for intramammary administration in milking animals |
| 04/22/2004 | WO2004032898A2 Controlled release system containing sucrose acetate isobutyrate |
| 04/22/2004 | WO2004032897A2 Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration |
| 04/22/2004 | WO2004032896A1 Nasallly applicable pharmaceutical preparation and the production thereof |
| 04/22/2004 | WO2004032881A2 Implantation of encapsulated biological materials for treating diseases |
| 04/22/2004 | WO2004032869A2 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
| 04/22/2004 | WO2004032866A2 Therapeutic formulations |
| 04/22/2004 | WO2004032863A2 Oral formulations for proteins and polypeptides |
| 04/22/2004 | WO2004032862A2 Cyclodextrin-based materials, compositions and uses related thereto |
| 04/22/2004 | WO2004032859A2 Water soluble sheet composition |
| 04/22/2004 | WO2004032858A2 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 04/22/2004 | WO2004032849A2 Methods of administering fgf18 |
| 04/22/2004 | WO2004032843A2 Mucoadhesive tetracycline formulations |
| 04/22/2004 | WO2004032826A2 Process for preparing tannate tablet capsule or other solid dosage forms |
| 04/22/2004 | WO2004032825A2 Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax |
| 04/22/2004 | WO2004032789A2 Liposomal hgh composition and method for administration thereof |
| 04/22/2004 | WO2004032718A2 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 04/22/2004 | WO2004032644A2 Chewing gum formulation and method of making the same |
| 04/22/2004 | WO2004032626A2 Method for treating an environment that may be or is contaminated with an undesirable bacteria, virus and/or spore |
| 04/22/2004 | WO2004019906A3 Method of manufacturing albumin microspheres comprising antisense oligonucleotides (oligomers) to nf-kb |
| 04/22/2004 | WO2004019758A3 Methods of treating idiopathic pulmonary fibrosis |
| 04/22/2004 | WO2004017941A3 Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist |
| 04/22/2004 | WO2004014156A3 A chemical carrier based on a beta-limit dextrin |
| 04/22/2004 | WO2004010975A3 Controlled drug delivery |
| 04/22/2004 | WO2004000372A3 Disinfecting composition, cleaning tablet produced therefrom, and use thereof |
| 04/22/2004 | WO2003105907A3 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 04/22/2004 | WO2003103596A8 Stabilized nanoparticle formulations of camptotheca derivatives |
| 04/22/2004 | WO2003103594A3 Micelle assemblies |
| 04/22/2004 | WO2003084476A3 Treatment of lung disorder |
| 04/22/2004 | WO2003063842A9 Composition for inhalation |
| 04/22/2004 | WO2003057164A3 Compounds for delivering substances into cells |
| 04/22/2004 | WO2003051452A8 Drug implant injection device |
| 04/22/2004 | WO2003051300A8 Metal complexes and formulations of rifamycin analogues and uses therof |
| 04/22/2004 | WO2003051299A8 Sulfhydryl rifamycins and uses thereof |
| 04/22/2004 | WO2003041686A3 Improved therapy for topical diseases |
| 04/22/2004 | WO2003028660A3 Drug delivery devices and methods |
| 04/22/2004 | WO2003020763A9 Soluble t cell receptor |
| 04/22/2004 | WO2003020211A3 Nitric oxide generation |
| 04/22/2004 | WO2002011711B1 Formulations of mometasone and a bronchodilator for pulmonary administration |
| 04/22/2004 | US20040078028 Plunger assembly for patient infusion device |
| 04/22/2004 | US20040078027 Method and apparatus for piezoelectric layer-wise pump and valve for use in local administration of biological response modifiers and therapeutic agents |
| 04/22/2004 | US20040077888 Polyamine-mediated transfection |
| 04/22/2004 | US20040077780 Thermogelling oligopeptide polymers |
| 04/22/2004 | US20040077735 Gels comprising hydrophilic nonionic surfactants, aliphatic alcohol, water, and oils, used as topical ointments or cosmetics |
| 04/22/2004 | US20040077724 Compositions comprising an o/w emulsion containing conjugated linoleic acid |
| 04/22/2004 | US20040077719 Food supplements, feed additives, dietetic, cosmetics |
| 04/22/2004 | US20040077717 Method of treating neutrophil-related diseases with topical anesthetics |